Open-label Extension of the HOPE-2 Trial
Open-label Extension of the HOPE-2 Trial
Active, not recruiting · NCT04428476 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-label Extension of the HOPE-2 Trial | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 2 | 2026-09-22 | NCT04428476 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Capricor Inc. | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital Colorado | Aurora | United States | 312 |
| Children's Hospital Wisconsin | Milwaukee | United States | 3 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| University of California, Davis | Sacramento | United States | 49 |
| Washington University | St Louis | United States | 182 |